CIRRHOSIS

作品数：1423被引量：7223H指数：35
导出分析报告
相关领域：医药卫生更多>>
相关作者：陆忠华于亚杰陈菊娣居朝霞周美芳更多>>
相关机构：中华医学会解放军第302医院香港大学复旦大学更多>>
相关期刊：更多>>
相关基金：国家自然科学基金国家重点基础研究发展计划国家高技术研究发展计划北京市自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 主题=HEPATITISx
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Clinical characteristics of patients with hepatitis and cirrhosis and the construction of a prediction model
《World Journal of Hepatology》2025年第2期54-64,共11页Yu-Shuang Huang Wei Gao Ai-Jun Sun Chun-Wen Pu Shuang-Shuang Xu 
Supported by the“Climbing Program”Construction Project“High Peak Project”Department of Major Infectious Disease Prevention and Control.
BACKGROUND Hepatitis B-associated cirrhosis is an important disease burden in China.However,there is a lack of effective predictors in clinical practice to drive delivery and enable early treatment to delay disease pr...
关键词：HEPATITIS Hepatitis B-related cirrhosis Clinical features Influencing factors NOMOGRAM 
Preoperative serum total bilirubin-albumin ratio as a prognostic indicator in patients with hepatitis-related cirrhosis after splenectomy
《World Journal of Gastrointestinal Surgery》2025年第1期70-80,共11页Yi-Fan Chen Yu-Xin Lin Miao-Miao Chi Da-Qing Li Lin-Tao Chen Yu Zhang Rong-Qian Wu Zhao-Qing Du 
BACKGROUND Splenectomy is an effective yet invasive intervention for alleviating portal pressure in patients with hepatitis cirrhosis.However,the current prognostic indicators for predicting long-term overall survival...
关键词：Serum total bilirubin-albumin ratio Hepatitis-related cirrhosis SPLENECTOMY Prognosis Survival 
Unraveling the Impact of Direct-Acting Antivirals on Hepatitis-Linked Cirrhosis: A Comprehensive Analysis of Fibrosis, Child Score, and Disease Progression
《Open Journal of Gastroenterology》2024年第6期203-212,共10页Hajar Cherkaoui Maryam Elkhayari Maria Lahlali Asmae Lamine Nada Lahmidani Amine Mekkaoui Mounia Elyousfi Dafr Allah Benajah Mohammed El Abkari Adil Ibrahimi Hakima Abid 
The treatment of hepatitis C has undergone a significant boom since the advent of direct acting antivirals (DAA). Indeed, the interferon-ribavirin combination that has been used to treat hepatitis C has a virological ...
关键词：Post-Viral Cirrhosis C Pegylated Interferon Direct Acting Antivirals Sustained Viral Response Child Score FIBROSIS 
Making Elimination of Perinatal Hepatitis B Infection a Reality:The Chinese Contribution
《Maternal-Fetal Medicine》2024年第2期67-69,共3页Jie Tang Kuanhui Xiang Yi-Hua Zhou 
This work was funded by the Health Commission of Nanjing City(ZKX20021);Science and Technology Department of Jiangsu Province(BK20221169);Jiangsu Province Center for Innovation in Obstetrics and Gynecology(CXZX202229),China.
Chronic hepatitis B virus(HBV)infection,referred to the presence of hepatitis B surface antigen(HBsAg)over 6 months,is a serious health issue because of its severe sequelae such as cirrhosis and hepatocellular carcino...
关键词：MOTHER HEPATITIS CIRRHOSIS 
Advances in the management of alcohol-associated liver disease
《Gastroenterology Report》2024年第1期731-746,共16页Ahmad Anouti Thomas A.Kerr Mack C.Mitchell Thomas G.Cotter 
T.G.C.is supported by the American Association for the Study of Liver Diseases(AASLD)Clinical,Translational and Outcomes Research Award(CTORA)and National Institute on Alcohol Abuse and Alcoholism(NIAAA)K23AA031310 grant;Research reported in this publication was supported by the NIAAA of the National Institutes of Health(NIH)under Award Number K23AA031310;The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.M.C.M.is supported by a grant from the National Institute on Alcohol Abuse and Alcoholism U01 AA026975;consults for GlaxoSmithKline,Amygdala NeProdigy,HepaTX,and Parvus;T.A.K.is supported by U01 AA026975 and has a research relationship with GSK and consults for Alexion.
Alcohol-associated liver disease(ALD)is a significant global health challenge,encompassing a spectrum from steatotic liver disease to cirrhosis and alcohol-associated hepatitis,and contributed to 25%of global cirrhosi...
关键词：alcohol-associated liver disease alcohol use disorder alcohol-associated hepatitis alcohol-associated cirrhosis steatotic liver disease 
Current and emerging therapies for alcohol-associated hepatitis
《Liver Research》2023年第1期35-46,共12页Francisco Idalsoaga Gustavo Ayares Luis Antonio Díaz Jorge Arnold María Ayala-Valverde David Hudson Marco Arrese Juan Pablo Arab 
Alcohol-related liver disease(ALD)encompasses a spectrum of diseases caused by excessive alcohol consumption.ALD includes hepatic steatosis,steatohepatitis,variable degrees of fibrosis,cirrhosis,and alcohol-associated...
关键词：Alcohol-associated hepatitis(AH) Alcohol-related liver disease(ALD) Alcohol use disorder(AUD) AUD treatment Nutritional therapy Steroids therapy CIRRHOSIS FIBROSIS 
Rising incidence,progression and changing patterns of liver disease in Wales 1999-2019
《World Journal of Hepatology》2023年第1期89-106,共18页Thomas Peter Ignatius Pembroke Gareth John Berry Puyk Keith Howkins Ruth Clarke Fidan Yousuf Marek Czajkowski Andrew Godkin Jane Salmon Andrew Yeoman 
BACKGROUND Liver disease incidence and hence demand on hepatology services is increasing.AIM To describe trends in incidence and natural history of liver diseases in Wales to inform effective provision of hepatology s...
关键词：EPIDEMIOLOGY CIRRHOSIS Liver failure Non-alcoholic fatty liver disease hepatitis Hepatocellular carcinoma 
Fibrolamellar hepatocellular carcinoma:A rare but unpleasant event被引量：2
《World Journal of Gastrointestinal Oncology》2022年第6期1103-1114,共12页Walaa Abdelhamed Mohamed El-Kassas 
Fibrolamellar carcinoma(FLC)is a rare variant of hepatocellular carcinoma(HCC),comprising 1%–9%of all HCCs.FLC is a poorly understood malignancy,which seems to be more prevalent in young patients with no underlying l...
关键词：Fibrolamellar carcinoma Hepatocellular carcinoma HEPATITIS CIRRHOSIS Viral hepatitis infection 
Efficacy and safety of sofosbuvir/velpatasvir with or without ribavirin in hepatitis C genotype 3 compensated cirrhosis:A meta-analysis
《World Journal of Hepatology》2022年第6期1248-1257,共10页Jing Hong Loo Wen Xin Flora Xu Jun Teck Low Wei Xuan Tay Le Shaun Ang Yew Chong Tam Prem Harichander Thurairajah Rahul Kumar Yu Jun Wong 
Supported by the Nurturing Clinician Scientist Scheme(NCCS)award by SingHealth Duke-NUS Academic Medical Centre and National Medical Research Council Singapore.
BACKGROUND Hepatitis C virus(HCV)is a leading cause of liver cirrhosis and hepatocellular carcinoma globally.Sofosbuvir/velpatasvir(SOF/VEL)is an effective pangenotypic direct-acting antiviral combination for treatmen...
关键词：Direct-acting antiviral Hepatitis C CIRRHOSIS Sofosbuvir/velpatasvir 
Vibration-controlled Transient Elastography for Assessment of Liver Fibrosis at a USA Academic Medical Center被引量：1
《Journal of Clinical and Translational Hepatology》2022年第2期197-206,共10页Max Shen Anna Lee Jay H.Lefkowitch Howard J.Worman 
supported by the Scholarly Projects Program at Columbia University Vagelos College of Physicians and Surgeons,which had no role in the design or execution of this study.
Background and Aims:Vibration-controlled transient elastography(VCTE)is a noninvasive tool that uses liver stiffness measurement(LSM)to assess fibrosis.Since real-life data during everyday clinical practice in the USA...
关键词：Chronic liver disease CIRRHOSIS HEPATITIS Liver histopathology Nonalcoholic fatty liver disease 
全选清除导出
共10页<12345678910>
检索报告 对象比较 聚类工具 使用帮助 返回顶部